Kemi Olugemo

CMO at Korro Bio

Speaker

Kemi Olugemo MD, Chief Medical Officer at Korro Bio, brings over 20 years of clinical research and biopharmaceutical industry experience, with expertise in nucleic acid therapies, biologics, and other modalities. Prior to joining Korro, Kemi was Vice President Global Clinical Development at Ultragenyx Pharmaceutical, and held positions of increasing responsibility at Parexel, Ionis Pharmaceuticals and Laronde. She holds several nonprofit board roles, and serves on the scientific committee of ISCTM, as well as CNS Summit’s leadership council.

Kemi’s contributions to health & gender equity resulted in multiple industry awards from peers as well as her alma mater. She completed her medical training and Neurology Residency at the University of Maryland School of Medicine, and an additional Fellowship in Neuroimmunology & Multiple Sclerosis at the Maryland Center for MS. She is a Fellow of the American Academy of Neurology.